Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
2021 · Ophthalmology and Therapy · 61 citations
https://doi.org/10.1007/s40123-021-00385-8
L
Lissa Padnick‐Silver
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
1.1K
Citations
18
h-index
24
i10-index
Lissa Padnick‐Silver is an academic researcher from Amgen (United States). The author has contributed to research in topics: Gout, Hyperuricemia, Uric Acid & Case Reports on Hematomas & Retinal Diseases and Treatments. The author has an h-index of 18, co-authored 51 publications.
ORCID: 0000-0002-4199-4844Papers by this author
worksPhysician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
2020 · Ophthalmology and Therapy · 28 citations
https://doi.org/10.1007/s40123-020-00318-x
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
2020 · Rheumatology and Therapy · 25 citations
https://doi.org/10.1007/s40744-020-00260-1
Comparison Between Early-Onset and Common Gout: A Systematic Literature Review
2023 · Rheumatology and Therapy · 14 citations
https://doi.org/10.1007/s40744-023-00565-x
Monosodium urate crystal depletion and bone erosion remodeling during pegloticase treatment in patients with uncontrolled gout: Exploratory dual-energy computed tomography findings from MIRROR RCT
2024 · Joint Bone Spine · 11 citations
https://doi.org/10.1016/j.jbspin.2024.105715
Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
2022 · Rheumatology and Therapy · 6 citations
https://doi.org/10.1007/s40744-022-00492-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat